The Human Fertilisation and Embryology Authority (HFEA) has approved the use of the gene editing tool CRISPR on human embryos for research purposes. After a petition by a Francis Crick Institute’s group studying genes involved in human embryo development, the U.K. regulatory body has made a distinction -regarding CRISPR use- between research and clinical applications. The team […]
